NCT00937937 2026-03-20
Dinaciclib in Treating Patients With Stage IV Melanoma
National Cancer Institute (NCI)
Phase 2 Active not recruiting
Clinical Trials
5 trialsNCT00871546 2015-08-07
SCH 727965 in Patients With Mantle Cell Lymphoma or B-Cell Chronic Lymphocytic Leukemia (Study P04715)
Merck Sharp & Dohme LLC
Phase 2 Terminated
NCT00732810 2015-08-05
SCH 727965 in Patients With Advanced Breast and Lung Cancers (Study P04716)
Merck Sharp & Dohme LLC
Phase 2 Completed
NCT00798213 2015-02-04
SCH 727965 in Patients With Acute Myelogenous Leukemia and Acute Lymphoblastic Leukemia (P04717AM2)(TERMINATED)
Merck Sharp & Dohme LLC
Phase 2 Terminated
NCT01096342 2014-06-18
Dinaciclib in Treating Patients With Relapsed or Refractory Multiple Myeloma
National Cancer Institute (NCI)
Phase 2 Completed